TrialHealth technology assessment (Winchester, England)2019

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.

Timothy Iveson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.